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Glucose metabolism: impact and significance on intracellular Ca2+ regulation 
 
Introduction 
 Glucose not only serves as a universal energy source for living cells, but also – and 
maybe this is not trivial for a lot of us - influences many intracellular signaling pathways. 
These pathways are involved e.g. in nutrient sensing, diabetic complications, stress response, 
post-translational modifications. My goal was to get a better view on the impact of glucose 
and its metabolites on one of the key elements of these intracellular signaling pathways: the 
[Ca2+]i regulation.  
 Increased level of glucose most of the time is associated with deleterious effects. 
However, there are situations where high glucose and consequently high metabolite levels can 
be beneficial. In all probability, the same pathways that are deleterious during a long term 
hyperglycemia also might cause the beneficial effect in an acute stress response. Glucose-
Insulin-Potassium (GIK) infusions e.g. are well known by invasive care specialists in the 
therapy of acute myocardial ischemia. Apart from the obvious function as ATP source, the 
underlining mechanism of the beneficial effect of glucose involves signaling pathways, one of 
them is the attenuation of the stress induced Ca2+ elevation.  
 Out of the 4 major known (diabetic) pathomechanisms (polyol pathway, AGE – 
advanced glycation endproducts, Protein kinase C activation, and hexosamine pathway) my 
thesis focuses on the hexosamine biosynthesis pathway (HBP). 2-4% of the glucose enters the 
HBP through the glutamine-fructose-6P aminotransferase (GFAT) which catalyses the L-
glutamine + D-fructose 6-phosphate = L-glutamate + D-glucosamine 6-phosphate reaction. 
Adding glucosamine directly to the cells bypasses the GFAT and enhances the flux through 
the HBP. The endproduct of the HBP is UDP-glcNAc (UDP-N-acetyl-glucosamine) which 
among other things serves as a source of protein-O-linked N-acetylglucosamine (also called: 
O-glcNAc or O-GlcNAcylation).  
The addition of O-GlcNAc to nuclear and cytoplasmic proteins, which is catalyzed by 
O-GlcNAc-transferase (OGT), is a dynamic and abundant posttranslational modification that 
has increasingly been recognized as an important regulatory mechanism in signal transduction 
and that also may be especially important in mediating the cellular stress response. O-glcNAc 
links to the serine, threonine OH-groups which means that on many proteins O-glcNAc 
competes with phosphorylation. The number of identified proteins capable of 
posttranslational O-glycosylation is quickly growing, including a wide range of proteins, such 
as NF-κB, annexin, endothelial nitric oxide synthase, αB-crystallin, OGT, α-tubulin, c-myc, 
and heat shock protein. Increased levels of O-glycosylation have been implicated in a range of 
cellular processes, including the development of insulin resistance in muscle, hyperglycemia-
induced apoptosis, and impaired excitation-contraction coupling. Recently, it also was shown 
that increased protein O-Glc-NAcylation occurs in a range of different cells in response to 
stress, suggesting that activation of this pathway may be a component of an endogenous cell 
survival pathway.  
In order to test the effect of increased HBP flux on cellular stress and on it’s central 
mediator: Ca2+ we applied AngII induced stress on isolated neonatal cardiomyocytes. AngII, 
through its receptor, couples to the Gq protein to stimulate PLC, generating two secondary 
messengers: diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). The major target of 
DAG is PKC, whereas IP3 triggers an increase in cytosolic Ca2+ concentration ([Ca2+]i) 
through IP3 receptors located in the sarcoplasmic reticulum. In most cell types, the IP3-
generated [Ca2+]i elevation is a consequence of an initial release from the endo-, sarcoplasmic 
reticulum followed by a subsequent influx of extracellular Ca2+ into the cytoplasm. This latter 
process is termed store-operated or capacitative Ca2+ entry (CCE). The intracellular targets of 
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[Ca2+]i are numerous and include, e.g., CaM-regulated kinases, calcineurin, PKC, MAPK, 
cytosolic phospholipase A2, and proteases.  
The goal of my study was to test the hypothesis that the impact of the HBP on the 
response of neonatal cardiomyocytes to the IP3-generating agonist AngII is mediated by an 
increase in protein O-GlcNAcylation that alters the regulation of [Ca2+]i. I found that 
glucosamine increased HBP flux in isolated neonatal cardiomyocytes, resulting in increased 
O-GlcNAc modification of proteins and attenuated AngII-induced [Ca2+]i elevation and also 
attenuated the CCE. I also demonstrate that independent of the HBP, up- or down regulation 
of protein O-GlcNAcylation directly influenced [Ca2+]i. These data demonstrate for the first 
time a direct link between protein O-GlcNAcylation and cardiomyocyte Ca2+ homeostasis, 
which may represent a novel mechanism for the regulation of cardiomyocyte function under 
normal and stress conditions.  
Phosphoglucomutase: 
Phosphoglucomutase (PGM) catalyzes the reversible conversion of glucose-6-P and glucose-
1-P, thus a key enzyme linking glucose and galactose metabolisms. It has been shown 
recently that the deletion of this enzyme causes significant changes in both the Ca2+ signaling 
and the Ca2+ storage in yeast. Therefore, PGM is a useful tool to understand how glucose 
metabolism influence[Ca2+]i.  
 There are multiple isoforms of PGM, deletion of all is lethal. In humans, beside the 
classical PGM activity (Glc-1-P – Glc-6-P conversion), another PGM activity can also be 
measured that recognizes both 5C and 6C sugars as substrates. Most probably PGM3 is 
responsible for this. PGM3 (also called: phosphoacetyl-glucosamine-mutase) has both 
classical PGM activity and also glcNAc-6P  glcNAc-1P activity, the later being part of the 
HBP. PGM3 has a high sequence homology with PGM1, and also needs Mg2+ to function. 
  It has been shown that Li+ inhibits PGM. This can be explained by the competition of 
Mg2+ and Li+. Since Li+ is used to treat bipolar patients but it’s underlying mechanism is 
unknown, investigating the effect of Li+ can not only help to understand the role of glucose 
metabolism in Ca2+ regulation but also might help to understand the molecular mechanisms 
involved in Li+ treatment in maniac disorders.  
 
 
 
 
Aims 
 
- to test whether the hexosamine pathway regulates [Ca2+]i homeostasis 
 
- if hexosamine pathway is involved in Ca2+ regulation, which participants of it is 
responsible? 
 
- through which process does the HBP modify Ca2+ regulation? Is CCE involved? 
 
- Can distinct proteins be identified that are both involved in Ca2+ regulation and influenced 
by HBP? 
 
- Since PGM3 is part of the HBP and PGM3 is closely related to PGM, can the inhibition of 
Li+ cause any change in HBP?  
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Materials and Methods 
Preparation of neonatal rat ventricular myocytes (NRVM):  Primary culture of NRVMs was 
obtained from 2-5 days old neonatal Sprague-Dawley rats and after isolation by collagenase 
digestion,  the cell suspensions from each digestion step were combined and centrifuged. The 
pellets were resuspended in DMEM:M199 (4:1), supplemented with 15% FBS, penicillin 
(100 U/mL) streptomycin (100 µg/mL) and arabinose C (10 µM).  Finally, NRVM were 
plated densely on 6-well plates (2*106 cells/well) or on 4 chambered coverslips (0.3*106 
cells/chamber) 
Jurkat cells: the cells were kept in glucose free RPMI-1640 supplemented with either 
glucose or galactose and with or w/o Li+.   
 
Ca2+ imaging: Spontaneously beating NRVMs washed in HBSS and loaded with 3 µM 
Fluo3-AM (Molecular Probes) for 45 min at 37°C. After loading with Fluo-3, NRVMs were 
washed 3 times with dye-free HBSS and finally the buffer was replaced with fresh HBSS 
containing 1.2 mM CaCl2 and 1.0 mM MgSO4.  Image acquisition was carried out at 37 °C on 
an Olympus IX70 inverted microscope. 
  
Immunoblotting with CTD110.6:  NRVMs or Jurkats were washed in ice-cold PBS, scraped 
and harvested in a modified RIPA buffer. Proteins were separated on 7.5% SDS-PAGE (27) 
and transferred to PVDF membrane. Blots were probed with CTD110.6, a monoclonal mouse 
IgM antibody that is highly specific for O-glycosylated proteins with no cross reactivity to 
similar carbohydrate antigens, in casein blocking buffer and followed with HRP conjugated 
mouse anti-IgM antibody.  For developing, Pico chemiluminescent substrate was used. 
 
Immunofluorescence microscopy:  NRVMs were plated on coverslips as indicated above 
and the cells were fixed in 3% formaldehyde/PBS, permeabilized with 0.5% Triton X-
100/PBS for 2 min.  The cells were rinsed in PBS and blocked in 5% bovine serum albumin 
(BSA)/PBS for 5 min. and then incubated with the CTD110.6. After rinsing in PBS, the 
coverslips were incubated with the secondary antibody Alexa-Fluor 594-conjugated goat anti-
mouse IgM. Image acquisition was performed with an Olympus IX70 inverted microscope.   
 
HPLC: The cells were precipitated with ice-cold 0.3 M perchloric acid (PCA).  PCA was 
extracted from the supernatant with 2 volumes of 1:4 trioctylamine:freon mixture. Samples 
were loaded on an anion exchange HPLC column (Partisil 10 SAX, Beckman) and nucleotide 
sugars were detected at 262 nm using 2 mL/min flow rate and linear salt and pH gradient from 
5 to 750 mM (NH4)H2PO4 and from pH 2.8 to 3.7, respectively.  
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Results and discussion 
 We supposed that the HBP influences the response of cells to stress, therefore we 
investigated the role of HBP in  [Ca2+]i regulation focusing on the end-product of HBP; the 
protein O-glcNAc. We used the agonist AngII to induce stress. AngII has positive inotropic 
effect, and causes hypertrophy and apoptosis. One of the most important acute effects of 
AngII is to increase the basal Ca2+ levels in cardiomyocytes.  
The effect of glucosamine on AngII induced stress:  Glucosamine bypasses GFAT by 
entering directly to HBP, increasing the levels of UDP-glcNAc and consequently protein O-
glcNAc. To prove that, we measured in NRVMs the UDP-glcNAc levels by HPLC, and the 
O-glcNAc levels by Western blot and immunofluorescence. As it turned out, a 5-10 exposure 
to glucosamine was enough to increase both UDP-glcNAc and O-glcNAc significantly (Fig. 
2). 
 Labeling NRVMs in vivo with Ca2+ sensitive fluorescence dye the rapid changes in 
Ca2+ caused by AngII can be observed using a fluorescence microscope. We found that AngII 
increased the rate of the beating, on the other hand significantly increased the basal Ca2+ 
levels (Fig 1). With glucosamine pretreatment, this increase in basal Ca2+ levels was inhibited. 
 
 
Fig. 1.: pretreatment with glucosamine for 5 min abolishes the effect of AngII (arrows) on 
NRVMs.  
 
 Since it was shown earlier that NRVMs exhibit CCE, we investigated whether 
glucosamine influences CCE. Treating NRVMs with thapsigargin (CCE-inducer drug) caused 
increased diastolic Ca2+ concentration, similarly to AngII. Pretreatment with glucosamine also 
blocked this thapsigargin induced increase.  
The effect of O-glcNAc on AngII induced stress: Based on this result, HBP seems to be 
involved in Ca2+ regulation but the question remains which part of it is responsible? We found 
that glucosamine not only influenced [Ca2+]i but also caused an increase in O-glcNAc. A large 
number of proteins were sensitive to glucosamine (Fig. 2).  
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Fig. 2: left: CTD 110.6 western-blot, right: densitometry, statistical analysis of 3 independent 
experiments. 
 
To prove that O-glcNAc directly influences [Ca2+]i we used specific inhibitors: 
PUGNAc (O-(2-acetamido-2-deoxy-D-glucopyranosylidene)-amino-N-phenyl-carbamate) 
inhibits O-glcNAcase which removes N-acetyl-glucosamine from the Ser/Thr side chains of 
proteins and alloxan which inhibits OGT. Since only a part of UDP-glcNAc is used up for O-
glcNAc, we haven’t seen any significant changes in UDP-glcNAc levels. On the other hand, 
PUGNAc increased the O-glcNAc levels while alloxan prevented glucosamine to increase it. 
Therefore any changes seen in Ca2+ regulation has to be caused by O-glcNAc and not the 
metabolites of HBP.  Pretreatment with alloxan didn’t change the AngII caused Ca2+ 
increase, however it prevented the inhibitory effect of glucosamine. In contrast, PUGNAc 
mimicked the effect of glucosamine, abolishing the AngII induced Ca2+ elevation. To further 
specify the effect of O-glcNAc on [Ca2+]i, we used thapsigargin to test O-glcNAc on CCE. It 
resulted in the same outcome, PUGNAc prevented the CCE, whereas alloxan blocked the 
inhibitory effect of glucosamine.  
The targets of O-glcNAc are numerous: transcription factors, cytoskeletal proteins, membrane 
proteins, kinases, etc. Supposedly the effect of O-glcNAc is not the result of the modification 
of one single protein but many others. However, the Trp (transient receptor potential) channel 
protein family, that is the prime candidate for the long sought CCE channel proteins and thus 
may be involved in the O-GlcNAc-mediated effects on Ca2+ homeostasis. Analysis of the 
protein sequence for Trp1, suggests a high affinity site for O-GlcNAc, close to the N-terminal 
region.  
The effect of Li+ on PGM and O-glcNAc: According to earlier result, PGM activity is 
closely related to Ca2+ homeostasis. Li+ was found to effectively inhibit the activity of PGM 
which opens up the possibility to further investigate the link between glucose metabolism and 
Ca2+. We propose that the missing link would be HBP and O-glcNAc. PGM3, part of the HBP 
pathway is a very similar protein to PGM therefore it could be either target for Li+, or partly 
overtake the function of PGM in case of an inhibition. Interestingly, treating Jurkat cells with 
Li+ caused an increase in O-glcNAc. This could be related to the assumption that blocking 
PGM (and possibly PGM3) caused a compensatory increased PGM3 expression which in turn 
elevated O-glcNAc. Our plan is to further investigate this phenomenon which eventually can 
lead also to better understand the underlying mechanism of Li+ treatment in bipolar patients. 
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